Embecta (Nasdaq:EMBC) announced today that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited.
MiniMed (Nasdaq:MMED) announced today that it received FDA clearance for the MiniMed Flex next-generation insulin pump.
Diabetes technology innovators gathered last week for the Advanced Technologies and Treatments for Diabetes Conference (ATTD 2026).
Senseonics (Nasdaq:SENS) announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.
Afon Technology says that its Glucowear non-invasive continuous glucose monitor (CGM) demonstrated significant accuracy in its first trial.
SiBionics shared new findings about the use of AI in continuous glucose monitor (CGM) technologies at ATTD 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results